Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1997
03/18/1997US5612316 Treatment of resistance to transplantation, fungal infections, and autoimmune diseases
03/18/1997US5612310 Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders
03/18/1997US5612217 Streptomyces sp. MA 7074 (ATCC 55605) used for microbial synthesis of HIV protease inhibitors
03/18/1997US5612207 Red blood cell
03/18/1997US5612206 Retrovirus infecting primate bone marrow cells and harvesting both non-adherent and adherent cells
03/18/1997US5612054 Treatment of diarrhea and flatulence in gastrointestinal disorders
03/18/1997US5612036 Crosslinked polypeptide vaccine with cysteine groups and carriers
03/18/1997US5612027 Eye surgery and maintaining pupil size by administering an acidic viscoelastic polymer
03/18/1997US5612026 Anion exchange resin, xanthan gum, water soluble salt
03/18/1997US5612019 Diagnosis and treatment of HIV viral infection using magnetic metal transferrin particles
03/18/1997US5611793 Disinfecting or sterilization tissues of mouths or wounds by applying photosensitizers
03/18/1997US5611464 Container for preserving media in the tip of a solution dispenser
03/18/1997CA2093045C Method for preparing low free formaldehyde methylolhydantoins and compositions thereof
03/18/1997CA2085136C Method for inhibition of retroviral replication
03/18/1997CA2083609C Preventive or therapeutic agent for ischemia-reperfusion tissue injury, arrhythmia and lung injury caused by active oxygens and free radicals
03/18/1997CA2076980C Method and product for promoting hair growth and treating skin conditions
03/18/1997CA2037101C Omeprazole compositions designed for administration in rectum
03/18/1997CA2036630C 1-phenoxycarbonyl-2-pyrrolidinone derivatives and nootropic agents
03/18/1997CA2010410C Process for the preparation of a valuable drug
03/18/1997CA2008341C Benzocycloalcenyl dihydroxy alcanoic acid derivatives, process for their preparation and drugs containing the same
03/18/1997CA2000937C Preparation of riboflavin-5'-phosphate (5'-fmn) and its sodium salt, and of riboflavin-4',5'-cyclophosphoric acid ester chloride as an intermediate
03/13/1997WO1997009442A1 Targeted nucleotide sequence delivery and integration system
03/13/1997WO1997009440A1 The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells
03/13/1997WO1997009429A2 Compounds and methods for diagnosis of tuberculosis
03/13/1997WO1997009428A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis
03/13/1997WO1997009427A1 Vegf-related protein
03/13/1997WO1997009351A1 Recombinant anti-cd4 antibodies for human therapy
03/13/1997WO1997009349A1 Binding protein
03/13/1997WO1997009343A2 Antagonists of the oncogenic activity of the protein mdm2, and use thereof in the treatment of cancers
03/13/1997WO1997009335A1 Substituted phosphinic compounds and their use as pharmaceuticals
03/13/1997WO1997009331A1 Cycloanthelmintic inhibitors
03/13/1997WO1997009329A1 Azo derivatives of 5-aminosalicylic acid for treatment of inflammatory bowel disease
03/13/1997WO1997009328A1 Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings
03/13/1997WO1997009325A1 Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions
03/13/1997WO1997009320A1 Alternate crystal form of tazofelone
03/13/1997WO1997009318A1 Pyrimidine derivatives
03/13/1997WO1997009317A2 Optically active phenyl pyrimidine derivative as analgesic agent
03/13/1997WO1997009315A1 Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions
03/13/1997WO1997009314A1 Novel 1-ar(alk)yl-imidazolin-2-ones containing a disubstituted amine radical in the 4th position, having an anti-convulsive effect, and process for their production
03/13/1997WO1997009311A1 New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
03/13/1997WO1997009309A1 4-(cycloalkyl)piperidine and 4-(cycloalkylalkyl)piperidine derivatives, preparation thereof and therapeutical applications thereof
03/13/1997WO1997009307A1 Retinoylamide based derivatives of sphingoid bases
03/13/1997WO1997009306A1 Novel isothiourea derivatives
03/13/1997WO1997009298A1 Production of an immunosuppressant using microorganisms
03/13/1997WO1997009297A2 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
03/13/1997WO1997009294A1 Carboxylic acid derivatives, their preparation and their use
03/13/1997WO1997009068A2 Interactive molecular conjugates
03/13/1997WO1997009067A1 Combination of 5-lipoxygenase and leukotriene synthesis inhibitors with glucocorticosteroids
03/13/1997WO1997009060A1 Method of treating insulin resistance
03/13/1997WO1997009056A1 Extract of iridaceae and compositions containing such extract
03/13/1997WO1997009053A1 2-deoxystreptamine as a molecular scaffold for preparing functionally and spatially diverse molecules and pharmaceutical compositions thereof
03/13/1997WO1997009052A1 Therapeutic azide compounds
03/13/1997WO1997009051A1 Analogs for specific oligosaccharide-neuregulin interactions and uses thereof
03/13/1997WO1997009049A2 Method for effecting vasodilation with (1,5-inter)aryl prostaglandin derivatives
03/13/1997WO1997009048A1 Use of a thienotriazolodiazepine to increase apolipoprotein a-i levels
03/13/1997WO1997009047A1 Remedy for diseases caused by infection with helicobacter
03/13/1997WO1997009046A1 Compounds and methods
03/13/1997WO1997009045A1 Use of a carbostyril derivative for inhibiting carcinogenesis
03/13/1997WO1997009044A1 Pentacyclic compounds, intermediates, processes, compositions, and methods
03/13/1997WO1997009043A1 Two-photon upconverting dyes and applications
03/13/1997WO1997009042A1 Pharmaceutical formulation
03/13/1997WO1997009041A1 Method of treatment for eiph in racing stock
03/13/1997WO1997009040A1 2-alkylpyrrolidines
03/13/1997WO1997009039A2 Composition comprising vitamin f
03/13/1997WO1997009034A1 Pharmaceutical compositions and devices for their administration
03/13/1997WO1997008960A1 Antistress agents for aquatic animals
03/13/1997WO1997008958A1 Sugar-free dragee-like products
03/13/1997WO1997008934A2 Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors
03/13/1997WO1997003345A3 Detection and quantification of human herpesvirus 7 by enzymic amplification dna virus dna
03/13/1997WO1997002826A3 Use of 19-nor-vitamin d compounds for the prevention of hyperphosphatemia in kidney disorder patients
03/13/1997WO1997001360A3 Compounds with chelation affinity and selectivity for first transition series elements and their use in medical therapy and diagnosis
03/13/1997WO1997001343A3 Utilization of sophorolipids as therapeutically active substances or cosmetic products, in particular for the treatment of the skin
03/13/1997WO1996041627A3 Iron compounds, compositions, methods of making the same and uses thereof
03/13/1997WO1996040106A3 Methods for controlling highly unsaturated fatty acid content in various tissues
03/13/1997WO1996040093A3 Bis phenol or phenozy compounds for immune modulation
03/13/1997WO1996040085A3 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
03/13/1997WO1996040054A3 Intraurethral pharmacotherapy of incontinence
03/13/1997WO1996039372A3 Macrophage lipid chemoattractant
03/13/1997WO1996035453A3 Endothelin antagonists and endothelin synthase inhibitors for the prevention and treatment of interine contractility disorders, preeclampsia, atherosclerotic vascular disease, hypertension and or hormone replacement therapy
03/13/1997WO1996028008A3 Novel cosmetic or dermatological compositions for controlling skin ageing
03/13/1997DE19533574A1 Use of materials with prolactinaemic activity as medicament
03/13/1997DE19533477A1 Use of di:ethylene-tri:amine-penta:acetic acid cpds.
03/13/1997DE19533330A1 Gegen Hautkrebs wirksame topische Zubereitungen Against skin cancer effective topical preparations
03/13/1997DE19533025A1 Neue Carbonsäurederivate, ihre Herstellung und Verwendung New carboxylic acid derivatives, their preparation and use
03/13/1997CA2684425A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis
03/13/1997CA2653566A1 Compounds and methods for immunotherapy and diagnosis of tuberculosis
03/13/1997CA2235415A1 2-alkylpyrrolidines
03/13/1997CA2231788A1 Targeted nucleotide sequence delivery and integration system
03/13/1997CA2231442A1 Therapeutic azide compounds
03/13/1997CA2231400A1 Vegf-related protein
03/13/1997CA2231326A1 Derivatives of 4- (cycloalkyl) piperidines and of 4- (cycloalkylalkyl) piperidines, their preparation and their therapeutic application
03/13/1997CA2231182A1 Recombinant anti-cd4 antibodies for human therapy
03/13/1997CA2231132A1 Alternate crystal form of tazofelone
03/13/1997CA2231114A1 Two-photon upconverting dyes and applications
03/13/1997CA2230974A1 Pentacyclic compounds, intermediates, processes, compositions, and methods
03/13/1997CA2230968A1 Method of treating insulin resistance
03/13/1997CA2230927A1 Compounds and methods for diagnosis of tuberculosis
03/13/1997CA2230896A1 Pyrimidine carboxylates and related compounds and methods for treating inflammatory conditions
03/13/1997CA2230894A1 Pyrimidine carboxamides and related compounds and methods for treating inflammatory conditions
03/13/1997CA2230687A1 Method for effecting vasodilation with (1,5-inter)aryl prostaglandin derivatives
1 ... 6817 6818 6819 6820 6821 6822 6823 6824 6825 6826 6827 6828 6829 6830 6831 6832 6833 6834 6835 6836 6837 ... 7860